Both in Biotechnology
ImmunityBio vs Vaxcyte
Over the past year IBRX returned +245.4% and PCVX returned +37.0%; their daily moves had a correlation of 0.27.
IBRX +245.4% PCVX +37.0%Growth of $1, one year, split-adjusted
| Metric | IBRX | PCVX |
|---|---|---|
| Price | $8.29 | $62.03 |
| Market cap | $8.79B | $9.76B |
| Today | −5.15% | −0.93% |
| 1 month | −10.7% | +10.7% |
| 6 months | +16.6% | +9.0% |
| Year to date | +318.7% | +34.4% |
| 1 year | +242.6% | +42.5% |
| Revenue growth (YoY) | +93.9% | — |
| Gross margin | 99.4% | — |
| Net margin | −449.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 53.0× | — |
| Net cash | -$57.7M | $1.49B |
| Dividend yield | — | — |
| Volatility (60d) | 68.0% | 70.5% |
| Short % of float | 31.1% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).